This code system http://terminology.hl7.org/CodeSystem/referencerange-meaning defines the following codes:
\n \n \n \n \n \n Lvl\n \n | \n \n \n \n Code\n \n | \n \n \n \n Display\n \n | \n \n \n \n Definition\n \n | \n \n
\n \n \n \n 1 | \n \n type\n \n \n \n | \n \n Type | \n \n General types of reference range. | \n \n
\n \n \n \n 2 | \n \n normal\n \n \n \n | \n \n Normal Range | \n \n Values expected for a normal member of the relevant control population being measured. Typically each results producer such as a laboratory has specific normal ranges and they are usually defined as within two standard deviations from the mean and account for 95.45% of this population. | \n \n
\n \n \n \n 2 | \n \n recommended\n \n \n \n | \n \n Recommended Range | \n \n The range that is recommended by a relevant professional body. | \n \n
\n \n \n \n 2 | \n \n treatment\n \n \n \n | \n \n Treatment Range | \n \n The range at which treatment would/should be considered. | \n \n
\n \n \n \n 2 | \n \n therapeutic\n \n \n \n | \n \n Therapeutic Desired Level | \n \n The optimal range for best therapeutic outcomes. | \n \n
\n \n \n \n 3 | \n \n pre\n \n \n \n | \n \n Pre Therapeutic Desired Level | \n \n The optimal range for best therapeutic outcomes for a specimen taken immediately before administration. | \n \n
\n \n \n \n 3 | \n \n post\n \n \n \n | \n \n Post Therapeutic Desired Level | \n \n The optimal range for best therapeutic outcomes for a specimen taken immediately after administration. | \n \n
\n \n \n \n 1 | \n \n endocrine\n \n \n \n | \n \n Endocrine | \n \n Endocrine related states that change the expected value. | \n \n
\n \n \n \n 2 | \n \n pre-puberty\n \n \n \n | \n \n Pre-Puberty | \n \n An expected range in an individual prior to puberty. | \n \n
\n \n \n \n 2 | \n \n follicular\n \n \n \n | \n \n Follicular Stage | \n \n An expected range in an individual during the follicular stage of the cycle. | \n \n
\n \n \n \n 2 | \n \n midcycle\n \n \n \n | \n \n MidCycle | \n \n An expected range in an individual during the midcycle stage of the cycle. | \n \n
\n \n \n \n 2 | \n \n luteal\n \n \n \n | \n \n Luteal | \n \n An expected range in an individual during the luteal stage of the cycle. | \n \n
\n \n \n \n 2 | \n \n postmenopausal\n \n \n \n | \n \n Post-Menopause | \n \n An expected range in an individual post-menopause. | \n \n
\n \n